Supplemental Figure 13 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fulv plus Olap treatment increases DNA damage in ESR1m Representative images of immunofluorescent staining of pH2AX foci in WT, Y537S and Y537C after cells were cultured in charcoal stripped medium for 48 hours, followed by treatment with 10 nM Fulvestrant, 5 µM Olaparib, or combination treatment.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Advanced Breast Cancer Therapies
Estrogen and related hormone effects
Publication details
- Publication date
- 2 April 2026
- Language
- EN